Tamoxifen 20 - Advar Pharma

Developed by ICI Pharmaceuticals, tamoxifen citrate emerged as a groundbreaking SERM with both estrogenic and anti-estrogenic properties. Approved by the FDA in 1977 for breast cancer treatment, it remains a staple in estrogen receptor-positive cancer management. In bodybuilding, tamoxifen is utilized to counteract estrogenic side effects from steroid cycles, such as gynecomastia. Additionally, it stimulates the release of luteinizing hormone (LH), aiding in testosterone production recovery during post-cycle therapy. This dual action makes it a versatile drug for both medical and athletic applications .

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Tamoxifen 20 by Advar Pharma, consult with your doctor or healthcare professional.